22:58
Nasdaq plans to delist BNB treasury company Windtree Therapeutics for violations.
Golden Finance reports that Nasdaq plans to delist BNB treasury company Windtree Therapeutics (stock code: WINT) due to the company's failure to comply with Nasdaq listing rule 5550 (a) (2)—which requires the minimum bid price of the stock to be maintained above $1. Windtree confirmed its non-compliance status in documents submitted to the U.S. Securities and Exchange Commission.
BNB3.41%
- 1